Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Miss Kathryn Berg
+44 (0)1316518726
kathryn.berg@ed.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Presentation and clinical outcome of pregnancy-associated osteoporosis

Presentation and clinical outcome of pregnancy-associated osteoporosis

Not Recruiting

Open to: All Genders

Age: Adult

Medical Conditions

Pregnancy-associated osteoporosis


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Pregnancy-associated osteoporosis (PAO) is a rare condition that typically presents with multiple vertebral fractures during pregnancy or lactation. The cause of PAO is poorly understood. It is known that bone is normally lost from the maternal skeleton during pregnancy and lactation to meet the needs of the growing foetus and infant during breastfeeding, but the degree of bone loss is modest and very rarely results in clinically apparent osteoporosis. It has been speculated that individuals who develop PAO may have pre-existing osteoporosis which worsens during pregnancy as the result of physiological bone loss or may experience exaggerated bone loss for reasons that are unclear. The aim of this study is to document the characteristics of women who have been diagnosed with PAO, its clinical features and the mode of disease presentation. A specific aim will be to explore the possible role of genetic factors by gathering information on family history of osteoporosis and PAO and conducting genetic profiling. A control group will also volunteer to give a blood sample for genetic profiling. The longer-term objective of the study is to gain a greater understanding of why PAO occurs in the hope that this will improve clinical outcomes in patients with this rare but serious condition.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

03 Nov 2021 30 Jun 2024

Phase 1: Answering an online questionnaire to give details about the demographics, clinical features, quality of life and treatment histories of participants.
Phase 2: Patients who complete the questionnaire can give optional consent to be contacted to give blood samples for genetic analysis at their local hospital and to have their medical records searched for information pertaining to their diagnosis.


1. Women who have been diagnosed with Pregnancy Associated Osteoporosis (PAO)
2. Women known to the PAO cases who gave birth at around the same time and who were not diagnosed with PAO.

You can take part if:



You may not be able to take part if:


Does not meet the inclusion criteria


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Queen Elizabeth University Hospital
    1345 Govan Road
    Glasgow
    G51 4TF
  • Western General Hospital
    Crewe Road South Edinburgh
    Lothian
    EH4 2XU
  • Royal Liverpool University Hospital
    Prescot Street
    Liverpool
    L7 8XP

There are no direct benefits to participants. There is a small risk of bruising during blood sampling.


The study is sponsored by Accord (United Kingdom) and funded by Royal Osteoporosis Society.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN27082949

Or CPMS 52578

Last updated 05 December 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.